European patients with benign prostatic hyperplasia (BPH): Differences in sexual dysfunction

Roger Kirby, Claus Roehrborn, Peter Boyle, Alain Jardin

Research output: Contribution to journalArticle

Abstract

INTRODUCTION: This study examined the relationship between cultural background and sexual dysfunction in BPH patients, from five European countries, enrolled into the Prospective European Doxazosin and Combination Trial (PREDICT). PATIENTS AND METHODS: The study investigated 826 patients, from France, Germany, Italy, the Netherlands and the UK. Patients were aged > 48 years with an International Prostatic Symptom Score (I-PSS) > 12 and peak urinary flow rate (Qmax) < 15 ml/sec. At study entry, general questions on sexual activity (sexually active, wish to be sexually active, regular panner) were asked during patient interview, then patients completed questionnaires on aspects of sexual dysfunction, in terms of frequency of problems (scale of 1 to 4, from once a month to almost always) and bothersomeness (scale of 0 to 4. from not at all to extremely). RESULTS: No statistical differences in BPH severity between countries were observed Although there were no differences in patients' desire to be sexually active, there were differences in actual activity (p<0.05; I, F vs. UK, G, NL) and presence of a regular partner (p<0.05, I, F, G vs. UK, NL). In all countries frequencies of sexual dysfunctions were high, with the most in Netherlands and the least in France, but, by contrast, bothersomeness was greatest in France and least in the Netherlands (Table). The frequency (F) and bothersomeness (B) scores were as follows: Sexual dysfunction France Germany Holland Italy UK F B F B F B F B F B Reduced sexual interest 2.5 1.6 2.2 1.3 2.6 0.6 2.2 0.8 2.6 1.1 Problems with: Gaining erection 2.3 1.9 2.7 1.7 2.9 0.6 2.4 1.2 2.8 1.1 Keeping erection 2.3 2.0 2.8 1.7 3.0 0.9 2.2 1.0 2.8 1.6 Completing act 2.3 1.8 2.5 1.4 2.1 0.8 2.4 1.5 2.6 1.5 Deriving satisfaction 2.3 1.6 2.4 1.4 2.8 0.7 2.4 1.2 2.6 1.7 CONCLUSIONS: This study recruited a large population of BPH patients from throughout Europe. There appears to be a large burden of sexual dysfunction in the BPH patient population, and there is considerable variation between countries.

Original languageEnglish (US)
Pages (from-to)193
Number of pages1
JournalBritish Journal of Urology
Volume80
Issue numberSUPPL. 2
StatePublished - 1997

Fingerprint

Prostatic Hyperplasia
Netherlands
France
Italy
Germany
Doxazosin
Sexual Behavior
Population
Interviews

ASJC Scopus subject areas

  • Urology

Cite this

European patients with benign prostatic hyperplasia (BPH) : Differences in sexual dysfunction. / Kirby, Roger; Roehrborn, Claus; Boyle, Peter; Jardin, Alain.

In: British Journal of Urology, Vol. 80, No. SUPPL. 2, 1997, p. 193.

Research output: Contribution to journalArticle

Kirby, Roger ; Roehrborn, Claus ; Boyle, Peter ; Jardin, Alain. / European patients with benign prostatic hyperplasia (BPH) : Differences in sexual dysfunction. In: British Journal of Urology. 1997 ; Vol. 80, No. SUPPL. 2. pp. 193.
@article{14dc277acf034b96ac633be67c49f401,
title = "European patients with benign prostatic hyperplasia (BPH): Differences in sexual dysfunction",
abstract = "INTRODUCTION: This study examined the relationship between cultural background and sexual dysfunction in BPH patients, from five European countries, enrolled into the Prospective European Doxazosin and Combination Trial (PREDICT). PATIENTS AND METHODS: The study investigated 826 patients, from France, Germany, Italy, the Netherlands and the UK. Patients were aged > 48 years with an International Prostatic Symptom Score (I-PSS) > 12 and peak urinary flow rate (Qmax) < 15 ml/sec. At study entry, general questions on sexual activity (sexually active, wish to be sexually active, regular panner) were asked during patient interview, then patients completed questionnaires on aspects of sexual dysfunction, in terms of frequency of problems (scale of 1 to 4, from once a month to almost always) and bothersomeness (scale of 0 to 4. from not at all to extremely). RESULTS: No statistical differences in BPH severity between countries were observed Although there were no differences in patients' desire to be sexually active, there were differences in actual activity (p<0.05; I, F vs. UK, G, NL) and presence of a regular partner (p<0.05, I, F, G vs. UK, NL). In all countries frequencies of sexual dysfunctions were high, with the most in Netherlands and the least in France, but, by contrast, bothersomeness was greatest in France and least in the Netherlands (Table). The frequency (F) and bothersomeness (B) scores were as follows: Sexual dysfunction France Germany Holland Italy UK F B F B F B F B F B Reduced sexual interest 2.5 1.6 2.2 1.3 2.6 0.6 2.2 0.8 2.6 1.1 Problems with: Gaining erection 2.3 1.9 2.7 1.7 2.9 0.6 2.4 1.2 2.8 1.1 Keeping erection 2.3 2.0 2.8 1.7 3.0 0.9 2.2 1.0 2.8 1.6 Completing act 2.3 1.8 2.5 1.4 2.1 0.8 2.4 1.5 2.6 1.5 Deriving satisfaction 2.3 1.6 2.4 1.4 2.8 0.7 2.4 1.2 2.6 1.7 CONCLUSIONS: This study recruited a large population of BPH patients from throughout Europe. There appears to be a large burden of sexual dysfunction in the BPH patient population, and there is considerable variation between countries.",
author = "Roger Kirby and Claus Roehrborn and Peter Boyle and Alain Jardin",
year = "1997",
language = "English (US)",
volume = "80",
pages = "193",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "SUPPL. 2",

}

TY - JOUR

T1 - European patients with benign prostatic hyperplasia (BPH)

T2 - Differences in sexual dysfunction

AU - Kirby, Roger

AU - Roehrborn, Claus

AU - Boyle, Peter

AU - Jardin, Alain

PY - 1997

Y1 - 1997

N2 - INTRODUCTION: This study examined the relationship between cultural background and sexual dysfunction in BPH patients, from five European countries, enrolled into the Prospective European Doxazosin and Combination Trial (PREDICT). PATIENTS AND METHODS: The study investigated 826 patients, from France, Germany, Italy, the Netherlands and the UK. Patients were aged > 48 years with an International Prostatic Symptom Score (I-PSS) > 12 and peak urinary flow rate (Qmax) < 15 ml/sec. At study entry, general questions on sexual activity (sexually active, wish to be sexually active, regular panner) were asked during patient interview, then patients completed questionnaires on aspects of sexual dysfunction, in terms of frequency of problems (scale of 1 to 4, from once a month to almost always) and bothersomeness (scale of 0 to 4. from not at all to extremely). RESULTS: No statistical differences in BPH severity between countries were observed Although there were no differences in patients' desire to be sexually active, there were differences in actual activity (p<0.05; I, F vs. UK, G, NL) and presence of a regular partner (p<0.05, I, F, G vs. UK, NL). In all countries frequencies of sexual dysfunctions were high, with the most in Netherlands and the least in France, but, by contrast, bothersomeness was greatest in France and least in the Netherlands (Table). The frequency (F) and bothersomeness (B) scores were as follows: Sexual dysfunction France Germany Holland Italy UK F B F B F B F B F B Reduced sexual interest 2.5 1.6 2.2 1.3 2.6 0.6 2.2 0.8 2.6 1.1 Problems with: Gaining erection 2.3 1.9 2.7 1.7 2.9 0.6 2.4 1.2 2.8 1.1 Keeping erection 2.3 2.0 2.8 1.7 3.0 0.9 2.2 1.0 2.8 1.6 Completing act 2.3 1.8 2.5 1.4 2.1 0.8 2.4 1.5 2.6 1.5 Deriving satisfaction 2.3 1.6 2.4 1.4 2.8 0.7 2.4 1.2 2.6 1.7 CONCLUSIONS: This study recruited a large population of BPH patients from throughout Europe. There appears to be a large burden of sexual dysfunction in the BPH patient population, and there is considerable variation between countries.

AB - INTRODUCTION: This study examined the relationship between cultural background and sexual dysfunction in BPH patients, from five European countries, enrolled into the Prospective European Doxazosin and Combination Trial (PREDICT). PATIENTS AND METHODS: The study investigated 826 patients, from France, Germany, Italy, the Netherlands and the UK. Patients were aged > 48 years with an International Prostatic Symptom Score (I-PSS) > 12 and peak urinary flow rate (Qmax) < 15 ml/sec. At study entry, general questions on sexual activity (sexually active, wish to be sexually active, regular panner) were asked during patient interview, then patients completed questionnaires on aspects of sexual dysfunction, in terms of frequency of problems (scale of 1 to 4, from once a month to almost always) and bothersomeness (scale of 0 to 4. from not at all to extremely). RESULTS: No statistical differences in BPH severity between countries were observed Although there were no differences in patients' desire to be sexually active, there were differences in actual activity (p<0.05; I, F vs. UK, G, NL) and presence of a regular partner (p<0.05, I, F, G vs. UK, NL). In all countries frequencies of sexual dysfunctions were high, with the most in Netherlands and the least in France, but, by contrast, bothersomeness was greatest in France and least in the Netherlands (Table). The frequency (F) and bothersomeness (B) scores were as follows: Sexual dysfunction France Germany Holland Italy UK F B F B F B F B F B Reduced sexual interest 2.5 1.6 2.2 1.3 2.6 0.6 2.2 0.8 2.6 1.1 Problems with: Gaining erection 2.3 1.9 2.7 1.7 2.9 0.6 2.4 1.2 2.8 1.1 Keeping erection 2.3 2.0 2.8 1.7 3.0 0.9 2.2 1.0 2.8 1.6 Completing act 2.3 1.8 2.5 1.4 2.1 0.8 2.4 1.5 2.6 1.5 Deriving satisfaction 2.3 1.6 2.4 1.4 2.8 0.7 2.4 1.2 2.6 1.7 CONCLUSIONS: This study recruited a large population of BPH patients from throughout Europe. There appears to be a large burden of sexual dysfunction in the BPH patient population, and there is considerable variation between countries.

UR - http://www.scopus.com/inward/record.url?scp=33749279426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749279426&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749279426

VL - 80

SP - 193

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - SUPPL. 2

ER -